Polymeric Nanoparticles: A Promising Tool to Enhance the Solubility of Poorly Water Soluble Drug

被引:1
作者
Kasekar, Nirmal M. [1 ]
Singh, Sarabjit [1 ]
Jadhav, K. R. [1 ]
Kadam, V. J. [1 ]
机构
[1] Bharati Vidyapeeths Coll Pharm, CBD, Sect 8, Navi Mumbai 400614, India
关键词
Itraconazole; poorly water soluble; eudragit; nanoparticles; HPLC; bioavailabilty; FORMULATION DEVELOPMENT; DISSOLUTION RATE; ITRACONAZOLE; DISPERSION; EZETIMIBE; DELIVERY;
D O I
10.2174/1574885514666190610125127
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: The objective of this study was to entrap water-insoluble drug itraconazole into polymer to form drug entrapped nanoparticles by using simple formulation strategy and characterize them for various in vitro properties. Method: Itraconazole (ITZ) encapsulated Eudragit E I00 nanoparticles (IEENs) were formulated by emulsification solvent evaporation technique. Results: Developed IEENs were evaluated for entrapment efficiency, particle size, polydispersity index, and drug release profile. It was clear that drug polymer ratio along with homogenization speed are the factors affecting droplet size of an emulsion. Evaluation was done by HPLC at 263nm. DSC, XRD studies were carried out. The in vitro antifungal study of nanoparticles suggested that they are more effective in inhibiting growth of Candida albicans. Conclusion: The results from this study suggest the potential use of IEENs to provide a possible way of improving solubility and thus oral absorption of Itraconazole. Thus the study concluded that IEENs have potential to effectively treat the fungal infection.
引用
收藏
页码:67 / 77
页数:11
相关论文
共 38 条
[1]   A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[2]  
Ananthanarayan R, 2009, LAB CONTROL ANTIMICR
[3]  
Eerikainen H., 2005, PREPARATION NANOPART
[4]   Formulation and optimization of itraconazole polymeric lipid hybrid nanoparticles (Lipomer) using box behnken design [J].
Gajra, Balaram ;
Dalwadi, Chintan ;
Patel, Ravi .
DARU-JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 23
[5]  
Hiendrawan S., 2015, International Journal of Pharmacy and Pharmaceutical Sciences, V7, P160
[6]   Phase I/II trial of pemetrexed plus nab-paclitaxel in advanced solid tumor patients with emphasis on non-small cell lung cancer [J].
Ho, Cheryl ;
Davies, Angela M. ;
Sangha, Randeep S. ;
Lau, Derick ;
Lara, Primo, Jr. ;
Chew, Helen K. ;
Beckett, Laurel ;
Mack, Philip C. ;
Riess, Jonathan W. ;
Gandara, David R. .
INVESTIGATIONAL NEW DRUGS, 2013, 31 (06) :1587-1591
[7]   Preparation, characterization, and in vitro release investigation of lutein/zein nanoparticles via solution enhanced dispersion by supercritical fluids [J].
Hu, Daode ;
Lin, Changchun ;
Liu, Liang ;
Li, Sining ;
Zhao, Yaping .
JOURNAL OF FOOD ENGINEERING, 2012, 109 (03) :545-552
[8]   Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs [J].
Jinno, J ;
Kamada, N ;
Miyake, M ;
Yamada, K ;
Mukai, T ;
Odomi, M ;
Toguchi, H ;
Liversidge, GG ;
Higaki, K ;
Kimura, T .
JOURNAL OF CONTROLLED RELEASE, 2006, 111 (1-2) :56-64
[9]   Enhanced solubility and dissolution rate of itraconazole by a solid dispersion technique [J].
Jung, JY ;
Yoo, SD ;
Lee, SH ;
Kim, KH ;
Yoon, DS ;
Lee, KH .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 187 (02) :209-218
[10]   Fabrication of drug nanoparticles by evaporative precipitation of nanosuspension [J].
Kakran, M. ;
Sahoo, N. G. ;
Li, L. ;
Judeh, Z. ;
Wang, Y. ;
Chong, K. ;
Loh, L. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2010, 383 (1-2) :285-292